Dysregulated expression of CXCR4/CXCL12 in subsets of patients with systemic lupus erythematosus

Arthritis and Rheumatism

Volumn 62, Issue 11, 2010, Pages 3436-3446

  Wang, Andrew ^a   Guilpain, Philippe ^b   Chong, Benjamin F ^a   Chouzenoux, Sandrine ^b   Guillevin, Loc ^b   Du, Yong ^a   Zhou, Xin J ^a   Lin, Fangming ^a   Fairhurst, Anna Marie ^a   Boudreaux, Christopher ^a   Roux, Christian ^b   Wakeland, Edward K ^a   Davis, Laurie S ^a   Batteux, Frederic ^b   Mohan, Chandra ^a  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CHEMOKINE RECEPTOR CXCR4; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RECEPTOR ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GLOMERULUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY PARENCHYMA; LEUKOCYTE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MENTAL PATIENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYSTEMIC LUPUS ERYTHEMATOSUS; UPREGULATION;

ADOLESCENT; ADULT; AGED; CHEMOKINE CXCL12; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTES; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; MIDDLE AGED; RECEPTORS, CXCR4; UP-REGULATION;

EID: 78249281043     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.27685     Document Type: Article

References (50)

1. Fairhurst AM, Wandstrat AE, Wakeland EK,. Systemic lupus erythematosus: multiple immunological phenotypes in a complex genetic disease. Adv Immunol 2006; 92: 1 - 69.
2. Banchereau J, Pascual V,. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 2006; 25: 383 - 92.
3. Kotzin BL,. Systemic lupus erythematosus. Cell 1996; 85: 303 - 6.
4. Davis JC, Tassiulas IO, Boumpas DT,. Lupus nephritis. Curr Opin Rheumatol 1996; 8: 415 - 23.
5. Deshmukh US, Bagavant H, Fu SM,. Role of anti-DNA antibodies in the pathogenesis of lupus nephritis. Autoimmun Rev 2006; 5: 414 - 8.
6. Turnberg D, Lewis M, Moss J, Xu Y, Botto M, Cook HT,. Complement activation contributes to both glomerular and tubulointerstitial damage in adriamycin nephropathy in mice. J Immunol 2006; 177: 4094 - 102.
7. Rhiannon JJ,. Systemic lupus erythematosus involving the nervous system: presentation, pathogenesis, and management. Clin Rev Allergy Immunol 2008; 34: 356 - 60.
8. Yoshio T, Onda K, Nara H, Minota S,. Association of IgG anti-NR2 glutamate receptor antibodies in cerebrospinal fluid with neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2006; 54: 675 - 8.
9. Yoshio T, Hirata D, Onda K, Nara H, Minota S,. Antiribosomal P protein antibodies in cerebrospinal fluid are associated with neuropsychiatric systemic lupus erythematosus. J Rheumatol 2005; 32: 34 - 9.
10. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B,. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001; 7: 1189 - 93.
11. Matus S, Burgos PV, Bravo-Zehnder M, Kraft R, Porras OH, Farias P, et al. Antiribosomal-P autoantibodies from psychiatric lupus target a novel neuronal surface protein causing calcium influx and apoptosis. J Exp Med 2007; 204: 3221 - 34.
12. Wang A, Fairhurst AM, Tus K, Subramanian S, Liu Y, Lin F, et al. CXCR4/CXCL12 hyperexpression plays a pivotal role in the pathogenesis of lupus. J Immunol 2009; 182: 4448 - 58.
13. + cells: role in transendothelial/stromal migration and engraftment of NOD/SCID mice. Blood 2000; 95: 3289 - 96.
14. + T cell activation. J Immunol 2000; 164: 5010 - 4.
15. Honczarenko M, Douglas RS, Mathias C, Lee B, Ratajczak MZ, Silberstein LE,. SDF-1 responsiveness does not correlate with CXCR4 expression levels of developing human bone marrow B cells. Blood 1999; 94: 2990 - 8.
16. Bleul CC, Farzan M, Choe H, Parolin C, Clark-Lewis I, Sodroski J, et al. The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry. Nature 1996; 382: 829 - 33.
17. Ponomaryov T, Peled A, Petit I, Taichman RS, Habler L, Sandbank J, et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 2000; 106: 1331 - 9.
18. Togel F, Isaac J, Hu Z, Weiss K, Westenfelder C,. Renal SDF-1 signals mobilization and homing of CXCR4-positive cells to the kidney after ischemic injury. Kidney Int 2005; 67: 1772 - 84.
19. Pablos JL, Amara A, Bouloc A, Santiago B, Caruz A, Galindo M, et al. Stromal-cell derived factor is expressed by dendritic cells and endothelium in human skin. Am J Pathol 1999; 155: 1577 - 86.
20. + hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1. Blood 1998; 91: 4523 - 30.
21. Wong D, Korz W,. Translating an antagonist of chemokine receptor CXCR4: from bench to bedside. Clin Cancer Res 2008; 14: 7975 - 80.
22. Tachibana K, Hirota S, Iizasa H, Yoshida H, Kawabata K, Kataoka Y, et al. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestinal tract. Nature 1998; 393: 591 - 4.
23. Nagasawa T, Hirota S, Tachibana K, Takakura N, Nishikawa S, Kitamura Y, et al. Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. Nature 1996; 382: 635 - 8.
24. Odemis V, Lamp E, Pezeshki G, Moepps B, Schilling K, Gierschik P, et al. Mice deficient in the chemokine receptor CXCR4 exhibit impaired limb innervation and myogenesis. Mol Cell Neurosci 2005; 30: 494 - 505.
25. Vicente-Manzanares M, Montoya MC, Mellado M, Frade JM, del Pozo MA, Nieto M, et al. The chemokine SDF-1α triggers a chemotactic response and induces cell polarization in human B lymphocytes. Eur J Immunol 1998; 28: 2197 - 207.
26. Li Y, Harada T, Juang YT, Kyttaris VC, Wang Y, Zidanic M, et al. Phosphorylated ERM is responsible for increased T cell polarization, adhesion, and migration in patients with systemic lupus erythematosus. J Immunol 2007; 178: 1938 - 47.
27. Harada T, Kyttaris V, Li Y, Juang YT, Wang Y, Tsokos GC,. Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration. Autoimmunity 2007; 40: 1 - 8.
28. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271 - 7.
29. ACR Ad Hoc Committee on Neuropsychiatric Lupus Syndromes. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599 - 608.
30. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630 - 40.
31. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al, on behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification of Lupus Nephritis. The classification of glomerulonephritis in systemic lupus erythematosus revisited [published erratum appears in J Am Soc Nephrol 2004;15:835-6]. J Am Soc Nephrol 2004; 15: 241 - 50.
32. Weening JJ, D'Agati VD, Schwartz MM, Seshan SV, Alpers CE, Appel GB, et al, on behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification of Lupus Nephritis. The classification of glomerulonephritis in systemic lupus erythematosus revisited [published erratum appears in Kidney Int 2004;65:1132]. Kidney Int 2004; 65: 521 - 30.
33. Bohnhorst JO, Bjorgan MB, Thoen JE, Natvig JB, Thompson KM,. Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren?s syndrome. J Immunol 2001; 167: 3610 - 8.
34. Hiramatsu N, Kuroiwa T, Ikeuchi H, Maeshima A, Kaneko Y, Hiromura K, et al. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. Rheumatology (Oxford) 2008; 47: 702 - 7.
35. Derksen RH, Hene RJ, Kater L,. The long-term clinical outcome of 56 patients with biopsy-proven lupus nephritis followed at a single center. Lupus 1992; 1: 97 - 103.
36. Ferluga D, Jerse M, Vizjak A, Hvala A, Rozman B, Kos-Golja M, et al. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE. Wien Klin Wochenschr 2000; 112: 692 - 701.
37. Bennett L, Palucka AK, Arce E, Cantrell V, Borvak J, Banchereau J, et al. Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. J Exp Med 2003; 197: 711 - 23.
38. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Ortmann WA, Espe KJ, et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc Natl Acad Sci U S A 2003; 100: 2610 - 5.
39. Bajetto A, Bonavia R, Barbero S, Piccioli P, Costa A, Florio T, et al. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J Neurochem 1999; 73: 2348 - 57.
40. Zou YR, Kottmann AH, Kuroda M, Taniuchi I, Littman DR,. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998; 393: 595 - 9.
41. Guyon A, Nahon JL,. Multiple actions of the chemokine stromal cell-derived factor-1α on neuronal activity. J Mol Endocrinol 2007; 38: 365 - 76.
42. Wu DT, Woodman SE, Weiss JM, McManus CM, D'Aversa TG, Hesselgesser J, et al. Mechanisms of leukocyte trafficking into the CNS. J Neurovirol 2000; 6 Suppl 1: S82 - 5.
43. Crazzolara R, Kreczy A, Mann G, Heitger A, Eibl G, Fink FM, et al. High expression of the chemokine receptor CXCR4 predicts extramedullary organ infiltration in childhood acute lymphoblastic leukaemia. Br J Haematol 2001; 115: 545 - 53.
44. Simon C, Juarez J, Nicolson GL, Boyd D,. Effect of PD 098059, a specific inhibitor of mitogen-activated protein kinase kinase, on urokinase expression and in vitro invasion. Cancer Res 1996; 56: 5369 - 74.
45. Krumbholz M, Theil D, Cepok S, Hemmer B, Kivisakk P, Ransohoff RM, et al. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006; 129: 200 - 11.
46. Balabanian K, Couderc J, Bouchet-Delbos L, Amara A, Berrebi D, Foussat A, et al. Role of the chemokine stromal cell-derived factor 1 in autoantibody production and nephritis in murine lupus. J Immunol 2003; 170: 3392 - 400.
47. Fritsch RD, Shen X, Illei GG, Yarboro CH, Prussin C, Hathcock KS, et al. Abnormal differentiation of memory T cells in systemic lupus erythematosus. Arthritis Rheum 2006; 54: 2184 - 97.
48. Fritsch RD, Shen X, Sims GP, Hathcock KS, Hodes RJ, Lipsky PE,. Stepwise differentiation of CD4 memory T cells defined by expression of CCR7 and CD27. J Immunol 2005; 175: 6489 - 97.
49. Henneken M, Dorner T, Burmester GR, Berek C,. Differential expression of chemokine receptors on peripheral blood B cells from patients with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther 2005; 7: R1001 - 13.
50. Amoura Z, Combadiere C, Faure S, Parizot C, Miyara M, Raphael D, et al. Roles of CCR2 and CXCR3 in the T cell-mediated response occurring during lupus flares. Arthritis Rheum 2003; 48: 3487 - 96.